Medicap Healthcare IPO Details
MAINBOARD
Medicap Healthcare IPO DRHP (Draft Red Herring Prospectus) has been Filed With SEBI.
The Lead Managers for Medicap Healthcare IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Aryaman Financial Services Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.
For detailed information, Refer to the Medicap Healthcare Limited DRHP.
Medicap Healthcare IPO Details
Medicap Healthcare IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
To be announced | |||
Medicap Healthcare IPO Reservation
Promoter Holding
Documents
Medicap Healthcare IPO Valuations
Medicap Healthcare Financial Information
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 216.29 | 105.89 | 98.35 |
| Total Income | 109.91 | 103.05 | 72.60 |
| Profit After Tax | 26.62 | 23.90 | 14.79 |
| EBITDA | 37.16 | 35.68 | 22.67 |
| NET Worth | 110.84 | 84.21 | 60.32 |
| Total Borrowing | 88.09 | 6.98 | 26.77 |
| Amount in ₹ Crore | |||
About Medicap Healthcare IPO
Incorporated on 2 June 2017, Medicap Healthcare Limited is in pharmaceutical packaging sector specializes in the production of pharmaceutical closures, including Euro Head caps and bottle preforms.
The company manufactures pharmaceutical packaging solutions, especially closures (e.g. Euro Head caps), Blood Collection Tubes (BCT), and components for Water for Injection (WFI) supply. It supplies pharma and healthcare industries.
The company operates from a 6,732 sq ft ultra-modern, state-of-the-art manufacturing facility with the latest technology.
Product Offerings:
- Euro Head Caps
- Bottle Preforms
- Miscellaneous (includes plastic and protector cap)
As on August 31, 2025, the company had 66 permanent employees.
Competitive Strengths:
- Well-positioned to capture favorable industry tailwinds in the growing pharma packaging caps and closure and bottle preforms market.
- Strategically located manufacturing facility coupled with quality-centric and precision-driven manufacturing infrastructure driving production efficiency.
- Robust domestic and global market presence driving sustainable growth.
- Long standing relationships with customers and suppliers with track record of repeat orders.
- Financial performance and growth due to specialized products.
Strength Of Medicap Healthcare IPO
Risk Of Medicap Healthcare IPO
Objectives Medicap Healthcare IPO
1. Purchase of plant and machinery for the existing Manufacturing Unit
2. Repayment or pre-payment, in full or part, of certain borrowings availed by the Company
3. Further Investment in the Subsidiary KASR Healthcare Private Limited for Repayment or pre-payment, in full or part, of certain borrowings availed by the Subsidiary Company
4. General Corporate Purposes
Company Contact Details
Medicap Healthcare Ltd
E-73,
GIDC Manjusar,
Vadodara, Gujarat, 391775
Phone: +91 97734 72846
Email: Investor.relations@medicapinc.com
Website: https://medicaphealthcare.in/
Registrar Contact Details
Lead Mangers
Lead Manager Reports
Medicap Healthcare IPO - FAQs
The Medicap Healthcare IPO is a MAINBOARD public issue comprising 0 equity shares with a face value of ₹10 each, aggregating to a total issue size of . The issue price has been fixed at ₹0 per equity share, and the minimum application size is 0 shares.
The IPO opens for subscription on TBA, and closes on TBA.
Kfin Technologies Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
As of now, the current GMP stands at TBA.